Skip to main content
Jinhai Medical Technology Limited logo

Jinhai Medical Technology Limited — Investor Relations & Filings

Ticker · 2225 ISIN · KYG5140Y1162 HKEX Administrative and support service activities
Open in API
Filings indexed 366 across all filing types
Latest filing 2026-05-12 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 2225

About Jinhai Medical Technology Limited

http://www.jin-hai.com.hk

Jinhai Medical Technology Limited is an investment holding entity engaged in two primary business segments. The first segment involves the provision of minimally invasive surgery solutions, medical products, and associated services, catering to the specialized needs of the healthcare industry. This focus includes offering advanced technologies and related support for surgical procedures. The second segment encompasses commercial services, including manpower outsourcing, ancillary support for building and construction contractors, dormitory services, and information technology (IT) services. The company leverages these diverse operations to serve both the medical and commercial sectors.

Recent filings

Filing Released Lang Actions
Form of Proxy for use at the Annual General Meeting to be held on Monday, 15 June 2026 (or any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a ‘Form of Proxy’ for shareholders to appoint proxies and vote at the Annual General Meeting. This is part of the proxy solicitation materials sent to shareholders requesting votes for resolutions at a meeting. It is not an actual AGM presentation nor the published annual report itself, but rather the voting solicitation form. This aligns with the Proxy Solicitation & Information Statement category (PSI).
2026-05-12 English
Notice of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 86% confidence The document is a formal notice convening the annual general meeting, detailing resolutions, proxy appointment, and voting arrangements, but contains no actual financial statements or presentation materials. It is sent to shareholders to provide information and request their votes for the AGM. This aligns with the Proxy Solicitation & Information Statement category.
2026-05-12 English
(1) Proposals for Grant of General Mandates to Issue Shares and Repurchase Shares, Extension of Issue Mandate, (2) Re-election of Directors, and Notice of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a shareholder circular issued by Jinhai Medical Technology Limited in advance of its 2026 Annual General Meeting. It includes proposals for share issue and repurchase mandates, re-election of directors, an explanatory statement, and the formal notice of AGM along with a proxy form. These characteristics match a Proxy Solicitation & Information Statement, rather than the AGM materials themselves, financial report, or dividend notice.
2026-05-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Major Shareholding Notification Classification · 95% confidence The document is a detailed monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, specifically reporting movements in securities, share capital, issued shares, share options, and confirmations related to compliance with listing rules. It is a regulatory submission concerning share capital and shareholding movements rather than a financial report, earnings release, or management discussion. The document is titled as a 'Monthly Return for Equity Issuer' and includes confirmations pursuant to listing rules. This type of filing corresponds to notifications about share capital and shareholding changes, which aligns with the category of Major Shareholding Notification (MRQ). The document is not an announcement of a report but the actual regulatory filing of shareholding movements and confirmations. Therefore, the appropriate classification is MRQ with high confidence.
2026-05-04 English
Annual Report 2025
Annual Report Classification · 100% confidence The document is titled '2025 Annual Report' for Jinhai Medical Technology Limited and contains comprehensive sections typical of an annual report, including Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Independent Auditor's Report, Consolidated Financial Statements, and Notes to the Financial Statements. The content covers the full fiscal year ended 31 December 2025, with detailed financial data and business review. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-04-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Exchange monthly return (Form FF301) detailing movements in authorised/registered share capital, issued shares, treasury shares, share options, and public float confirmation for the month ended 31 March 2026. It is not a financial report (10-K, IR), earnings release, management commentary, or AGM materials, but a regulatory disclosure of share capital changes and share issuances. This fits the category for Share Issue/Capital Change (Code: SHA).
2026-04-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.